Avatrombopag in adults with immune thrombocytopenia: A multicentre real-life observational study in Madrid, Spain (AVAMAD study)

被引：0

作者：

Pascual-Izquierdo, Cristina ^{[1
]}

Llacer-Ferrandis, Ma. Jose ^{[1
]}

de-la-Iglesia, Almudena ^{[2
]}

Monsalvo-Saornil, Silvia ^{[2
]}

Menor-Gomez, Maria ^{[3
]}

Gil-Fernandez, Juan Jose ^{[3
]}

Chica-Gullon, Esther ^{[4
]}

alvarez-Roman, Maria Teresa ^{[5
]}

Perez-Segura, Gloria ^{[6
]}

Zafra, Denis ^{[6
]}

Ortuzar-Pasalodos, Ariana ^{[7
]}

Gonzalez-Gascon-y-Marin, Isabel Teresa ^{[8
]}

Moreno, Gemma ^{[9
]}

Arquero-Portero, Teresa ^{[10
]}

Moreno-Carbonell, Marta ^{[1
]}

Revilla, Nuria ^{[10
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Inst Invest Gregorio Maranon, Hematol, Madrid, Spain

[2] Hosp Univ Puerta Hierro, Hematol, Madrid, Spain

[3] Hosp Univ Principe Asturias, Hematol, Madrid, Spain

[4] Hosp Univ Getafe, Madrid, Spain

[5] Hosp Univ La Paz, Hematol, Madrid, Spain

[6] Hosp Univ 12 Octubre, Hematol, Madrid, Spain

[7] Hosp Univ Rey Juan Carlos, Hematol, Madrid, Spain

[8] Hosp Univ Infanta Leonor, Hematol, Madrid, Spain

[9] Hosp Univ Ramon & Cajal, Hematol, Madrid, Spain

[10] Hosp Univ Fdn Jimenez Diaz, Inst Invest Fdn Jimenez Diaz IIS FJD, Hematol, Madrid, Spain

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 02期

关键词：

avatrombopag; immune thrombocytopenia; ITP; TPO-RA;

D O I：

10.1111/bjh.19975

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Immune thrombocytopenia (ITP) is a rare acquired disorder where thrombopoietin-receptor agonists have become mainstays of ITP treatment. With the recent approval of avatrombopag (AVA), real-world studies are essential to evaluate its efficacy and safety. Our study of 66 adult ITP patients treated with AVA showed a high response rate. After starting AVA, 74.2% did not require rescue medications, with minimal adverse effects. Additionally, 56.0% of patients reduced other ITP medications, and all patients aged >= 65 years responded to AVA. Results should be confirmed in larger studies, but AVA appears to be an effective and safe treatment for ITP patients.

引用

页码：652 / 656

页数：5

共 50 条

[31] Therapeutic efficacy and clinical effectiveness of mycophenolate mofetil and dexamethasone for immune thrombocytopenia: A retrospective observational study
Wasekar, Nilesh
Badarkhe, Girish
Pandit, Sudarshan
Ramesh, Yasam Venkata
Nagarkar, Raj
IRAQI JOURNAL OF HEMATOLOGY, 2021, 10 (01) : 28 - 33
[32] A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice
Steurer, Michael
Quittet, Philippe
Papadaki, Helen A.
Selleslag, Dominik
Viallard, Jean-Francois
Kaiafa, Georgia
Janssens, Ann
Kozak, Tomas
Wadenvik, Hans
Schoonen, Marieke
Belton, Laura
Kreuzbauer, Georg
EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (02) : 112 - 120
[33] Spotlight on eltrombopag concentration in pediatric immune thrombocytopenia: A single-center observational study in China
Dong Shuyue
Wang Zhifa
Wang Nan
Ma Jingyao
Meng Jinxi
Sun Yixin
Cheng Xiaoling
Wu Runhui
儿科学研究（英文）, 2024, 08 (01)
[34] SINGLE-CENTRE REAL-LIFE EXPERIENCE ON THE USE OF THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CHILDREN
Obrisca, Radu
Colita, Anca
Serbanica, Andreea
Bica, Ana Maria
Jercan, Cristina
Marcu, Andra Daniela
Radu, Letitia Elena
Marcu, Ana Maria
Colita, Andrei
Orban, Carmen
FARMACIA, 2024, 72 (01) : 185 - 192
[35] Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles
Emilie Reboursiere
H. Fouques
G. Maigne
H. Johnson
S. Chantepie
A. C. Gac
O. Reman
M. Macro
K. Benabed
X. Troussard
G. Damaj
S. Cheze
International Journal of Hematology, 2016, 104 : 85 - 91
[36] Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles
Reboursiere, Emilie
Fouques, H.
Maigne, G.
Johnson, H.
Chantepie, S.
Gac, A. C.
Reman, O.
Macro, M.
Benabed, K.
Troussard, X.
Damaj, G.
Cheze, S.
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (01) : 85 - 91
[37] The predictive value of regulatory T cells on glucocorticoid sensitivity in patients with immune thrombocytopenia: a multicentre, prospective clinical study
Li, Li
Zhao, Yanhong
Tong, Xiwen
Li, Yi
Huang, Lifang
Hui, Yan
Mao, Xia
Wei, Jia
Shang, Zhen
Wang, Long
Xiang, Hang
Guo, Jingming
Chang, Wei
Zhang, Xinhua
Liu, Longlong
Gao, Kaibo
Zhang, Donghua
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 619 - 627
[38] Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study
Weber, E.
Moulis, G.
Mahevas, M.
Guy, C.
Lioger, B.
Durieu, I.
Hunault, M.
Ramanantsoa, M.
Royer, B.
Default, A.
Perault-Pochat, M. -C.
Moachon, L.
Bernard, N.
Bardy, G.
Jonville-Bera, A. -P.
Geniaux, H.
Godeau, B.
Cathebra, P.
REVUE DE MEDECINE INTERNE, 2017, 38 (03): : 167 - 175
[39] Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre prospective cohort study
Parodi, Emilia
Russo, Giovanna
Farruggia, Piero
Notarangelo, Lucia D.
Giraudo, Maria T.
Nardi, Margherita
Giona, Fiorina
Giordano, Paola
Ramenghi, Ugo
BLOOD TRANSFUSION, 2020, 18 (05) : 396 - 405
[40] Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain-The Fostasur Study
Jimenez-Barcenas, Reyes
Garcia-Donas-Gabaldon, Gloria
Campos-Alvarez, Rosa Maria
de Mora, Maria Carmen Fernandez-Sanchez
Luis-Navarro, Josefa
Dominguez-Rodriguez, Juan Francisco
Nieto-Hernandez, Maria del Mar
Sanchez-Bazan, Irene
Yera-Cobo, Maria
Cardesa-Cabrera, Rocio
Jimenez-Gonzalo, Francisco Jose
Ruiz-Cobo, Maria Antonia
Caparros-Miranda, Isabel
Entrena-Urena, Laura
Jimenez, Dolores Fernandez
Diaz-Canales, Dana
Moreno-Carrasco, Gloria
Calderon-Cabrera, Cristina
Nunez-Vazquez, Ramiro Jose
Pedrote-Amador, Begona
Mingot-Castellano, Maria Eva
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 1977 - 1985

← 1 2 3 4 5 →